Smallpox Treatment Market: Brincidofovir Lipid Conjugation and Double-Stranded DNA Inhibitors
Advancements in lipid-conjugate nucleotide technology, extended intracellular drug half-lives, and reduced nephrotoxicity risks are driving progress in the nucleotide segment of the Smallpox Treatment Market. Brincidofovir represents an innovative lipid-conjugated prodrug of cidofovir engineered to overcome severe kidney toxicity while enhancing oral bio-availability. In addition, lipid...
0 Commentarii 0 Distribuiri 94 Views 0 previzualizare